NEWS

March 14, 2024

Dimerix fast-tracks kidney drug trial via new cash raise

MELBOURNE: Dimerix will rapidly expand the phase three clinical trial of its flagship ... read more

March 14, 2024

Mesoblast gets boost from positive FDA news in USA

MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more

March 14, 2024

Analysts give Paragon-CH2 deal a thumbs up

MELBOURNE: Analysts at Bell Potter are backing the back door listing of the ... read more

March 14, 2024

Bupa Asia PAcific navigates 2023 financial landscape with aplomb

SYDNEY: Bupa Asia Pacific has revealed its financial results for the year ending ... read more